Performance of 18F-DCFPyL PET/CT Imaging in Early Detection of Biochemically Recurrent Prostate Cancer: A Systematic Review and Meta-Analysis

Background: Prostate-specific membrane antigen (PSMA)-targeted 2-(3-{1-carboxy-5-[(6-[18F] fluoro-pyridine-3-carbonyl)-amino]-pentyl}-ureido)-pentanedioic acid (18F-DCFPyL) positron emission tomography/computed tomography (PET/CT) has shown advantages in primary staging, restaging, and metastasis de...

Descripción completa

Detalles Bibliográficos
Autores principales: Sun, Jiale, Lin, Yuxin, Wei, Xuedong, Ouyang, Jun, Huang, Yuhua, Ling, Zhixin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8107478/
https://www.ncbi.nlm.nih.gov/pubmed/33981607
http://dx.doi.org/10.3389/fonc.2021.649171

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8107478/
https://www.ncbi.nlm.nih.gov/pubmed/33981607
http://dx.doi.org/10.3389/fonc.2021.649171

Ejemplares similares